Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis.

about

Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis.

Item

http://www.wikidata.org/entity/Q49269072

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@en

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@nl

type

Item

label

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@en

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@nl

prefLabel

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@en

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@nl

P1476

Relapsing-Remitting Multiple S ...... ed with multivariate analysis.

@en

P2093

Bedile Irem Tiftikcioglu

http://www.w3.org/2001/XMLSchema#string

Dilek Yonar

http://www.w3.org/2001/XMLSchema#string

Levent Ocek

http://www.w3.org/2001/XMLSchema#string

Yasar Zorlu

http://www.w3.org/2001/XMLSchema#string

P2860

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Using Fourier transform IR spectroscopy to analyze biological materials

Revised diagnostic criteria of multiple sclerosis.

Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.

Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects.

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.

Fourier transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of Alzheimer's disease.

Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.

P304

1025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-19303-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Feride Severcan

P577

2018-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29348591

http://www.w3.org/2001/XMLSchema#string

P921

relapsing-remitting multiple sclerosis

infrared spectroscopy

multiple sclerosis

P932

5773569

http://www.w3.org/2001/XMLSchema#string